India To Dedicate First Indigenous H5N1 Vaccine for Chickens
A domestically made killed-virus vaccine promises targeted protection for commercial layer and breeder flocks to curb mass culling and farm losses.
Overview
- The vaccine was developed by ICAR-National Institute of High Security Animal Diseases and will be formally dedicated to the nation by Agriculture Minister Shivraj Singh Chouhan on Friday, Nov. 20.
- Developers describe the product as an inactivated (killed-virus) vaccine engineered against H5N1 Clade 2.3.2.1a, the strain linked to most recent chicken outbreaks in India.
- Trial reports from the developers say a single dose gave encouraging safety and effectiveness results in layer and breeder chickens and is expected to protect birds for up to six months.
- Health and industry context: H5N1 can kill nearly all infected poultry, has been detected in mammals and a small number of humans, and WHO records show 1,003 human cases with 479 deaths globally since 2003.
- Officials say the vaccine is meant mainly for commercial farms to strengthen prevention and outbreak response, which could limit large-scale culling, reduce trade disruption, and protect farmer incomes.